As of April 30, 2025, Biora Therapeutics (BIOR) has a market cap of $994,994 Dollars USD. According to our data, Biora Therapeutics is ranked No.9237 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 30, 2025 | $994,994 Dollars |
0.00%
|
Dec 31, 2024 | $0.99 M |
-98.37%
|
Dec 29, 2023 | $61.06 M |
-59.00%
|
Dec 30, 2022 | $0.15 B |
-93.70%
|
Dec 31, 2021 | $2.36 B |
-60.64%
|
Dec 31, 2020 | $6.00 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Intellia Therapeutics
NTLA
|
$0.85 B |
-0.000 M
|
![]() USA
|
![]() Editas Medicine
EDIT
|
$0.13 B |
0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.23 B |
-0.000 M
|
![]() Switzerland
|
![]() Beam Therapeutics
BEAM
|
$1.98 B |
-0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.16 B |
0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$40.34 M |
0.000 M
|
![]() USA
|
![]() REGENXBIO
RGNX
|
$0.47 B |
0.000 M
|
![]() USA
|
![]() Voyager Therapeutics
VYGR
|
$0.20 B |
0.000 M
|
![]() USA
|
![]() Precision BioSciences
DTIL
|
$55.18 M |
0.000 M
|
![]() USA
|
![]() Editas Medicine
EDIT
|
$0.13 B |
0.000 M
|
![]() USA
|
![]() Allogene Therapeutics
ALLO
|
$0.33 B |
-0.000 M
|
![]() USA
|
![]() Fate Therapeutics
FATE
|
$0.13 B |
-0.000 M
|
![]() USA
|
![]() Rocket Pharmaceuticals
RCKT
|
$0.78 B |
0.000 M
|
![]() USA
|
Market Cap | = | BIOR Stock Price | * | BIOR Shares Outstanding |
= | $0.22 | * | 4.52 M | |
= | $994,994 Dollars |